2.3 Dialysate Composition, Acid-Base Balance, and Electrolyte Dynamics

2.3 Dialysate Composition, Acid-Base Balance, and Electrolyte Dynamics

Core Principle: Dialysate is a non-sterile, highly formulated aqueous electrolyte solution balanced to correct uremic metabolic acidosis, normalize extracellular electrolyte concentrations, and prevent osmotic fluid shifts. The advanced clinical technician must understand the chemical interactions of proportioning systems, the electrophysiology of electrolyte shifts, and the life-threatening risks of incorrect bath formulations.

Dialysate Proportioning Systems and Chemical Formulation

Dialysate is prepared dynamically at the bedside by the hemodialysis machine's proportioning system, which blends three continuous fluid streams:

1. AAMI/ISO-Grade Purified Water: Treated by reverse osmosis and deionization, representing approximately 95% to 98% of total volume.
2. Acid Concentrate ("A" Component): Formulated with sodium chloride, potassium chloride, calcium chloride, magnesium chloride, dextrose, and a small quantity of an organic acid (acetic acid [2.0–4.0 mEq/L] or citric acid).
3. Bicarbonate Concentrate ("B" Component): Contains dissolved sodium bicarbonate (NaHCO₃), sometimes with added sodium chloride to enhance electrical conductivity.

The Chemical Rationale for Concentrate Separation

A universal rule of hemodialysis chemistry is that acid concentrate and bicarbonate concentrate must never be mixed together in concentrated form. When divalent cations—specifically calcium (Ca²⁺) and magnesium (Mg²⁺)—encounter high concentrations of bicarbonate (HCO₃⁻) at alkaline pH, they undergo immediate precipitation reactions:

Ca²⁺ + 2HCO₃⁻ → CaCO₃ ↓ + H₂O + CO₂

Mg²⁺ + 2HCO₃⁻ → MgCO₃ ↓ + H₂O + CO₂

These insoluble carbonate salts form a rock-like white precipitate that would rapidly clog internal proportioning pumps, seize flow valves, blind optical sensors, and deplete the delivered dialysate of ionized calcium. By keeping the acid and bicarbonate concentrates physically separate until both are diluted into treated water, the concentrations of Ca²⁺, Mg²⁺, and HCO₃⁻ remain low enough to stay completely dissolved in solution.

Proportioning Mixing Ratios

Dialysis machines utilize fixed dilution proportioning ratios based on manufacturer specifications:

• 45x Proportioning System (Standard): 1 part acid concentrate + 1.72 parts bicarbonate concentrate + 42.28 parts purified water = 45 total parts.
• 35x / 36.83x Proportioning System: 1 part acid concentrate + 1.225 parts bicarbonate concentrate + 32.775 parts purified water = 35 total parts (or 1:1.83:34 for 36.83x).

Mixing concentrates designed for a 35x system on a machine calibrated for 45x creates severe chemical compounding errors, producing dangerous hypo- or hyper-osmolar dialysate.

---

Electrolyte Dynamics and Clinical Formulations

---

Specific Component Kinetics and Safety Protocols

1. Sodium Concentration and Sodium Modeling Risks

Sodium is the principal determinant of extracellular fluid (ECF) osmolality. Dialysate sodium is generally prescribed between 135 and 145 mEq/L to align with the patient's baseline serum sodium:

• Sodium Modeling (Profiling): A prescribed program where dialysate sodium is set high (e.g., 145–148 mEq/L) at the beginning of treatment to maintain vascular filling and suppress intradialytic hypotension and cramping, then ramped downward (e.g., to 138 mEq/L) by treatment end.
• The Clinical Hazard: Sodium modeling introduces a positive diffusional sodium load into the patient. Post-dialysis hypernatremia stimulates hypothalamic osmoreceptors, driving intense, uncontrollable thirst. The patient consumes excessive water between treatments, resulting in massive interdialytic weight gains (IDWG), volume overload, severe hypertension, and accelerated left ventricular hypertrophy (LVH). Both KDIGO and CMS discourage routine sodium modeling.

2. Potassium Baths and Myocardial Electrophysiology

Because dietary potassium cannot be excreted by failing kidneys, hyperkalemia (K⁺ > 5.5 mEq/L) represents a constant risk of fatal cardiac arrest. Dialysate potassium must be carefully individualized:

• 1.0 mEq/L Potassium Bath: Indicated for severe pre-dialysis hyperkalemia (K⁺ > 6.5 mEq/L). Establishes a steep concentration gradient to clear potassium rapidly.
• 2.0 mEq/L Potassium Bath: The standard maintenance bath for the majority of patients with moderate pre-dialysis hyperkalemia (K⁺ = 5.0 - 6.5 mEq/L).
• 3.0 mEq/L Potassium Bath: Prescribed for patients with pre-dialysis potassium levels ≤ 4.5 mEq/L, or patients taking digitalis glycosides (digoxin).

3. Calcium Balance and Bone Mineral Metabolism

Diffusible (ionized) calcium accounts for approximately 50% of total serum calcium, with the remainder bound to albumin. Dialysate calcium concentrations determine net calcium mass balance:

• 2.5 mEq/L (1.25 mmol/L): Yields a neutral to slightly negative calcium balance. It is the preferred bath for patients with hypercalcemia, low PTH levels (adynamic bone disease), severe vascular calcification, or those taking high doses of calcium-based phosphate binders and active vitamin D analogs.
• 3.0 mEq/L (1.50 mmol/L): The standard maintenance bath for achieving neutral calcium balance in stable ESRD patients.
• 3.5 mEq/L (1.75 mmol/L): Produces a positive calcium balance. It is reserved for severe hypocalcemia, secondary hyperparathyroidism requiring PTH suppression, or following parathyroidectomy ("hungry bone syndrome").

4. Magnesium Balance

ESRD patients are unable to excrete dietary magnesium. Maintenance dialysate contains 0.5 to 1.0 mEq/L of magnesium. This modest gradient facilitates mild diffusional clearance, preventing hypermagnesemia, which causes central nervous system depression, impaired neuromuscular transmission, and cardiac conduction abnormalities.

5. Acid-Base Homeostasis: Bicarbonate vs. Historical Acetate

Uremic patients suffer from chronic metabolic acidosis due to the failure of the kidneys to synthesize new bicarbonate and excrete metabolic hydrogen ions (H⁺ derived from protein catabolism). Dialysate delivers 32 to 38 mEq/L of bicarbonate into the blood compartment via diffusion, restoring depleted plasma buffer stores to achieve a pre-dialysis serum bicarbonate target of ≥ 22 mEq/L.

• Historical Acetate Dialysate: Prior to the 1980s, sodium acetate was used because it did not precipitate with calcium. However, acetate required hepatic conversion into bicarbonate. In many patients, blood acetate accumulation exceeded metabolic capacity, producing severe vasodilation, refractory intradialytic hypotension, severe headaches, nausea, and myocardial depression. Modern bicarbonate dialysate has eliminated acetate-induced toxicity.
• pH Stabilization: To prevent bicarbonate from breaking down into carbonate in the machine hydraulics, a small amount of acid (acetic or citric acid, 2–4 mEq/L) is incorporated, maintaining final dialysate pH between 6.9 and 7.4.

6. Dextrose Addition

Dialysate contains 100 to 200 mg/dL (5.5–11.1 mmol/L) of dextrose. Using glucose-free dialysate causes rapid diffusive loss of 25 to 35 grams of glucose into the dialysate, triggering acute intradialytic hypoglycemia (especially in diabetic patients receiving insulin) and accelerating gluconeogenesis, muscle protein catabolism, and lipolysis.

---

Machine Monitoring and Pre-Treatment Verification

Dialysis machines monitor dialysate preparation continuously through internal conductivity and temperature sensors:

1. Total Conductivity: Measures the electrical conductance of all dissolved ionic salts combined, expressed in milliSiemens per centimeter (mS/cm). Normal operating ranges typically fall between 13.0 and 15.5 mS/cm.
2. Safe Bypass System: If conductivity deviates by more than ±5% from target, or if temperature exceeds 39.0°C, the machine automatically trips into bypass mode, diverting dialysate away from the dialyzer to the drain to protect the patient from chemical injury or thermal hemolysis.
3. Mandatory Independent Pre-Treatment Verification: CMS Conditions for Coverage mandate that before every treatment, the technician must manually verify the dialysate using an independent, calibrated external meter:
   • Independent Conductivity: Must verify within ±0.2 to 0.4 mS/cm of theoretical machine conductivity.
   • Independent pH: Must test between 6.9 and 7.4.

---

Clinical Scenario: The Digoxin-Potassium Collision

A 70-year-old female with ESRD secondary to diabetic nephropathy presents for her Monday hemodialysis session. Her pre-dialysis serum potassium is 4.7 mEq/L. The patient has a history of chronic atrial fibrillation managed with digoxin 0.125 mg daily. The patient station was previously used for a patient requiring an aggressive 1.0 K+ bath, and the acid concentrate jug attached to the machine is a 1.0 mEq/L potassium formulation.

The technician notices the 1.0 K+ concentrate during pre-treatment setup. Recognizing that the patient takes digoxin, the technician immediately halts priming and consults the charge nurse to verify the prescription.

Pathophysiology: Administering a 1.0 mEq/L potassium bath creates a steep diffusion gradient that rapidly drives serum potassium below 3.5 mEq/L. Hypokalemia markedly enhances digoxin toxicity by increasing digoxin binding to myocardial Na⁺/K⁺-ATPase pumps. This triggers lethal ventricular arrhythmias, including frequent premature ventricular contractions, ventricular tachycardia, and complete heart block. The technician replaces the concentrate with a 3.0 mEq/L potassium formulation, safely averting cardiac arrest.

---

Advanced Exam Traps: Conductivity Alarms and Dialysate Inversion

• The Hypotonic Dialysate Hemolysis Trap: If proportioning fails or treated water overwhelms the concentrate lines without triggering bypass, dialysate conductivity plummets. Exposing blood to severely hypotonic dialysate drives water across red blood cell membranes via osmosis. The cells swell and burst, causing massive acute intravascular hemolysis. The technician will observe translucent "port-wine" or "cherry-red" blood in the venous bloodline, and the patient will complain of acute burning in the access arm, chest tightness, severe back pain, and dyspnea, rapidly followed by hyperkalemic cardiac arrest.
• The Inverted Wand Trap: Inadvertently placing the red acid suction wand into the bicarbonate jug and the blue bicarbonate wand into the acid jug causes catastrophic hydraulic failure, rapid salt precipitation, and extreme acid-base deviations, which must be caught during manual pH/conductivity testing before connecting to the patient.